Overview
- The Ludwig-Maximilians-Universität inaugurated the MaxP3 diagnostics and research centre in München-Großhadern in June 2026 to consolidate dispersed labs and speed patient care.
- Patient samples now travel by pneumatic-tube to automated laboratory lines that use robotics and planned AI-assisted analysis to cut diagnostic turnaround times.
- The centre includes about 1,100 m² of lab space, a roughly 100 m² biosafety level 3 laboratory for agents such as tuberculosis and SARS-CoV-2, and it does not handle BSL-4 pathogens like Ebola which are managed by the Robert Koch Institute or Bundeswehr clinics.
- On-site infrastructure also features a nitrogen cryogenic biobank with -80°C storage, a small immunization and consultation clinic, and two national reference centres for Helicobacter pylori and for retroviruses including HIV.
- The €36 million facility is staffed by roughly 90 people and is intended to shorten the time from sample to treatment, improve surveillance capacity in Bavaria, and centralize specialist testing close to the LMU hospital.